Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Endometrial Neoplasms × inavolisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 7 Solid Tumors 1 PIK3CA-Mutated Cancers 1 Neoplasms 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 HER2-positive Breast Cancer 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 21 Paclitaxel 19 Carboplatin 17 Specimen Handling 12 Bevacizumab 11 Letrozole 8 dostarlimab 7 Magnetic Resonance Spectroscopy 7 Biopsy 7 abemaciclib 6 Fulvestrant 6 Taxes 5 Megestrol Acetate 5 Cisplatin 5 Blood Specimen Collection 5 trastuzumab deruxtecan 4 olaparib 4 Observation 4 Medroxyprogesterone Acetate 4 Immunoglobulin G 4 Drug Therapy 4 Doxorubicin 4 palbociclib 3 lenvatinib 3 X-Rays 3 Radiotherapy 3 Progestins 3 Nivolumab 3 Gemcitabine 3 Docetaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04486352 2025-09-04

EndoMAP

Alliance Foundation Trials, LLC.

Phase 1/2 Recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡